CRUK Consent Forms – Bladder cancer immunotherapy regimens

Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website.

A new form for Nivolumab has been added.

Revalidation of the remaining regimen specific consent forms are in progress and will be updated in due course.

All forms can be found at www.cruk.org/sact_consent.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA Research Committee on 21st November 2024

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article
By BOPA Committee on 18th November 2024

ISOPP CAPhO Symposium 2025

ISOPP CAPhO Symposium 2025 (ISOPP CAPhO 2025) is taking place April 3-6 (Symposium) and April 7 (Masterclasses) at the Victoria Conference Centre, Victoria, British Columbia, Canada. The Symposium is hosted…

Read article
By BOPA Education and Training Subcommittee on 18th November 2024

Project to link members to MPharm course in the UK

Dear BOPA Members, The Education & Training subcommittee are working on a project to link BOPA members into every undergraduate MPharm course in the UK, with the aim of providing…

Read article
By EDI Subcommittee on 8th November 2024

BOPA EDI membership survey

We invite you to take part in a quick BOPA EDI membership survey. Your responses will assist the BOPA Equity, Diversity and Inclusion (EDI) subcommittee to better serve the membership…

Read article